Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Multiple myeloma treatment has advanced with new therapies, increasing life expectancy from under 3 years to over a decade. Health disparities persist, with Black patients facing higher diagnosis ...

The stage of diagnosis can impact survival rates. Patients with stage III multiple myeloma (MM) have an average life expectancy of 29 months, whereas patients with stages I and II disease survive on ...

Lynozyfic (linvoseltamab-gcpt) is a prescription injection medicine for people with a type of blood cancer called multiple myeloma, whose cancer has come back (relapsed) or worsened (refractory) after ...

How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...

Cancer stories, as we’ve long told them, tend to follow one of two arcs: diagnosis, then a brave fight against the disease resulting either in survival or death. But journalist Jonathan Gluck’s story ...

Stage 3 multiple myeloma is defined by high beta-2 microglobulin, elevated LDH, and high-risk genetic abnormalities. Diagnosis involves CRAB criteria and tests like bone marrow biopsy, imaging, and ...

Palliative care that recognizes patient goals and values is essential, starting at diagnos ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...